News & Articles

Discover how Merck’s new Estapor Intense Color Microspheres promise increased sensitivity, stability, and multiplexing capability for lateral flow tests

Perform quantitative analyses of the biological nanoparticles and demonstrate properties for cellular communication and disease progression or inhibition

Harness exhaled breath for real-time monitoring of microbial metabolites and health impacts

Join online from any time zone and stay up to date with the latest breath biopsy research

Olink is sponsoring a Cancer Biomarker Discovery Challenge for Innovative Researchers in Europe

Discover how digital laboratory tools provider eLabNext is teaming up with artificial intelligence (AI) software companies to create new, integrated AI laboratory solutions

Explore the versatile role of ddPCR technology in immuno-oncology for precise and sensitive nucleic acid quantification

Join us for thought-provoking conversations with leading scientists as we reflect on the remarkable achievements of science and explore the possibilities ahead

Learn about remarkable advances in sepsis diagnosis and monitoring over the past 25 years as we highlight some of the most notable breakthroughs.

Watch exclusive video interviews with industry experts on advances in biomarker discovery, breakthroughs in cancer diagnostics, and more

Discover the game-changing advancements and key discussions driving lab automation forward

Goal of the project is to provide a device to every warfighter in the field where access to diagnostic testing or medical personnel is limited

Prof. Umberto Malapelle, Chair of Predictive Molecular Pathology Laboratory and Scientific Secretary of the International Society of Liquid Biopsy shares insights on how predictive molecular pathology could improve targeted therapies and personalized care

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on spectroscopy, proteomics sample preparation, efficient, cost-effective, and value-based healthcare, and more

Fujirebio adds another two markers to its fully automated blood-based biomarker portfolio

The new biomarker tests will allow further study of the clinical utility of NfL in diverse disease conditions

Discover the latest tools and techniques to expand your research capacity with expert-led presentations on RNA therapies, immunotherapies, antibody-drug conjugates, and more

The new partnership will aim to advance the development of antigen-targeted EVOC probes for early cancer detection

Strategic partnership aims to accelerate biomarker development to improve the diagnosis of Alzheimer’s disease and and other neurological disorders

How can a proteomics platform that can measure over 7,000 protein biomarkers from one sample be used to assess an individual’s overall health, monitor disease progression, and inform healthcare decisions?